Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07421219Not Yet Recruiting

ARTEMIS - The ARTEMIS Cohort

Role: collaborator

NCT04617639Not ApplicableEnrolling By Invitation

The Norwegian Trial of Physical Exercise After Myocardial Infarction

Role: collaborator

NCT06855121Recruiting

The Norwegian Immunotherapy in Multiple Myeloma Study

Role: collaborator

All 3 trials loaded